KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Exchange Rate Effect (2016 - 2025)

Nektar Therapeutics (NKTR) has 16 years of Exchange Rate Effect data on record, last reported at $1000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect rose 103.57% year-over-year to $1000.0; the TTM value through Sep 2025 reached $39000.0, up 234.48%, while the annual FY2024 figure was -$4000.0, 106.45% down from the prior year.
  • Exchange Rate Effect reached $1000.0 in Q3 2025 per NKTR's latest filing, down from $6000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $107000.0 in Q2 2023 and bottomed at -$295000.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$18684.2, with a median of -$8000.0 recorded in 2024.
  • Peak YoY movement for Exchange Rate Effect: tumbled 1080.0% in 2022, then skyrocketed 700.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$10000.0 in 2021, then surged by 650.0% to $55000.0 in 2022, then plummeted by 85.45% to $8000.0 in 2023, then skyrocketed by 312.5% to $33000.0 in 2024, then plummeted by 96.97% to $1000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $1000.0 in Q3 2025, $6000.0 in Q2 2025, and -$1000.0 in Q1 2025.